The device delivers continuous flow oxygen therapy in a compact, portable design for patients in the United States.
Inogen Inc, a manufacturer of respiratory products for homecare use, has announced the release of the Voxi 5, a new stationary oxygen concentrator designed to support long-term oxygen therapy for patients in home settings.
The Voxi 5 delivers one to five liters per minute of continuous flow oxygen and is designed for quiet operation. Developed in collaboration with Yuwell Medical, the system features a compact footprint, built-in caster wheels for mobility between rooms, and an eight-layer internal gas pathway intended to maintain oxygen purity.
According to the company, the Voxi 5 oxygen concentrator serves as a lower-cost alternative to its Inogen At Home unit, offering an option for price-sensitive users or as a secondary device for multi-room use.
“With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients,” says Kevin Smith, president and chief executive officer, in a release. “This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy.”
Product features of the Voxi 5 oxygen concentrator include:
- Continuous flow oxygen delivery (1–5 L/min)
- Lockable casters for ease of movement
- Designed for quiet operation
- Three-year sieve bed warranty
- Advanced filtration system for medical-grade oxygen
Voxi 5 is now available in the United States through Inogen’s existing distribution channels.
Photo caption: Voxi 5
Photo credit: Inogen
